Caveolin‐1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases
- 9 July 2009
- journal article
- Published by Wiley in Histopathology
- Vol. 55 (1) , 20-27
Abstract
To study caveolin-1 (Cav-1) expression in metastatic lung carcinomas. Cav-1 expression was investigated in a series of 121 lung carcinomas and it was shown that 18/121 tumours (14.9%) were Cav-1+. None of the pure bronchioloalveolar carcinomas proved to be positive, vs. 42.8% of the large cell carcinomas (neuroendocrine subtype excluded). Adenocarcinomas (8.5%), large cell neuroendocrine carcinomas (20%) and squamous cell carcinomas (29.6%) displayed an intermediate percentage of positive cases, suggesting a gradient of Cav-1 expression according to tumour histotype-related aggressiveness. Moreover, the percentage of Cav-1+ tumours with distant metastases was almost double that of non-metastatic tumours (17.8% vs. 8.1%), irrespective of the histotype. In 34 tumours metastatic to the brain, primary and secondary lesions were compared and 53% of brain metastases were Cav-1+ vs. 20.6% of primaries, indicating a de novo acquisition of Cav-1 expression. This pattern was exclusive to the brain, as it was not acquired in adrenal metastases. In our series, the presence of epidermal growth factor receptor amplification, determined by fluorescence in situ hybridization, was not related to Cav-1 reactivity. Cav-1 immunoreactivity in lung carcinoma is histotype-dependent and acquired de novo in brain metastases, suggesting a site-specific phenotypic shift in secondary lesions.Keywords
This publication has 26 references indexed in Scilit:
- Caveats of caveolin-1 in cancer progressionCancer Letters, 2008
- Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPasesJournal of Cell Biology, 2007
- Caveolin-1 Expression is Variably Displayed in Astroglial-derived Tumors and Absent in Oligodendrogliomas: Concrete Premises for a New Reliable Diagnostic Marker in GliomasAmerican Journal of Surgical Pathology, 2007
- Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization AnalysisClinical Cancer Research, 2007
- Caveolin-1 and regulation of cellular cholesterol homeostasisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Simultaneous Expression of Caveolin-1 and E-Cadherin in Ovarian Carcinoma Cells Stabilizes Adherens Junctions through Inhibition of src-Related KinasesThe American Journal of Pathology, 2005
- Caveolin-1 in oncogenic transformation, cancer, and metastasisAmerican Journal of Physiology-Cell Physiology, 2005
- Down-Regulation of Caveolin-1, a Candidate Tumor Suppressor Gene, in SarcomasThe American Journal of Pathology, 2001
- p42/44 MAP Kinase-dependent and -independent Signaling Pathways Regulate Caveolin-1 Gene ExpressionJournal of Biological Chemistry, 1999
- Reduction of Caveolin 1 Gene Expression in Lung Carcinoma Cell LinesBiochemical and Biophysical Research Communications, 1999